| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...9912963P |
| P356 | DOI | 10.1073/PNAS.162471999 |
| P932 | PMC publication ID | 130569 |
| P698 | PubMed publication ID | 12297621 |
| P5875 | ResearchGate publication ID | 11125153 |
| P50 | author | Patrick O. Brown | Q546092 |
| David Botstein | Q1173787 | ||
| Robert Tibshirani | Q3938444 | ||
| Anne-Lise Børresen-Dale | Q11958220 | ||
| Per Eystein Lønning | Q11995192 | ||
| Stefanie S Jeffrey | Q64681693 | ||
| Jonathan R. Pollack | Q73921770 | ||
| Christian A. Rees | Q74026886 | ||
| Charles M. Perou | Q30503513 | ||
| Therese Sørlie | Q60034610 | ||
| P2860 | cites work | Molecular cytogenetics of primary breast cancer by CGH | Q74382796 |
| Silence of chromosomal amplifications in colon cancer | Q77678758 | ||
| Initial sequencing and analysis of the human genome | Q21045365 | ||
| How aneuploidy affects metabolic control and causes cancer | Q24531520 | ||
| Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization | Q24564349 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays | Q29615979 | ||
| Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors | Q29618818 | ||
| Genome-wide analysis of DNA copy-number changes using cDNA microarrays | Q29618942 | ||
| Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances | Q32168348 | ||
| Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. | Q33180996 | ||
| Pieces of the puzzle: expressed sequence tags and the catalog of human genes | Q33368363 | ||
| Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells | Q36822801 | ||
| The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis | Q40766945 | ||
| Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene | Q41738933 | ||
| Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer. | Q46171268 | ||
| Widespread aneuploidy revealed by DNA microarray expression profiling | Q52923550 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12963-12968 | |
| P577 | publication date | 2002-09-24 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors | |
| P478 | volume | 99 |
| Q24629750 | 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis |
| Q37165239 | 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. |
| Q34473399 | 14-3-3ζ as a prognostic marker and therapeutic target for cancer |
| Q34419358 | A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes |
| Q42040178 | A New Normalizing Algorithm for BAC CGH Arrays with Quality Control Metrics |
| Q41458656 | A Novel Graph-based Algorithm to Infer Recurrent Copy Number Variations in Cancer |
| Q34658145 | A Prognosis Classifier for Breast Cancer Based on Conserved Gene Regulation between Mammary Gland Development and Tumorigenesis: A Multiscale Statistical Model |
| Q35900958 | A Single-Array-Based Method for Detecting Copy Number Variants Using Affymetrix High Density SNP Arrays and its Application to Breast Cancer |
| Q38377260 | A bayesian analysis for identifying DNA copy number variations using a compound poisson process |
| Q34078670 | A cancer-specific transcriptional signature in human neoplasia |
| Q24647928 | A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes |
| Q34325538 | A comprehensive continuous-time model for the appearance of CGH signal due to chromosomal missegregations during mitosis |
| Q37318482 | A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets |
| Q33577478 | A critical assessment of cross-species detection of gene duplicates using comparative genomic hybridization |
| Q33532752 | A double-layered mixture model for the joint analysis of DNA copy number and gene expression data |
| Q33923176 | A fused lasso latent feature model for analyzing multi-sample aCGH data |
| Q33932557 | A general lack of compensation for gene dosage in yeast |
| Q38582323 | A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer |
| Q40216522 | A hierarchical clustering method for estimating copy number variation |
| Q35872162 | A model for gene deregulation detection using expression data. |
| Q24810612 | A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females |
| Q35832269 | A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes |
| Q52085673 | A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome |
| Q40090503 | A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays |
| Q36545417 | A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker |
| Q30440217 | A novel method for gene expression mapping of metastatic competence in human bladder cancer |
| Q37229908 | A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis |
| Q35916012 | A perspective on DNA microarrays in pathology research and practice |
| Q30571667 | A predictive framework for integrating disparate genomic data types using sample-specific gene set enrichment analysis and multi-task learning |
| Q33317061 | A process for analysis of microarray comparative genomics hybridisation studies for bacterial genomes |
| Q41959377 | A prognostic model for the combined analysis of gene expression profiling in hepatocellular carcinoma |
| Q30985488 | A robust Correntropy-based method for analyzing multisample aCGH data |
| Q33325344 | A sequence-based survey of the complex structural organization of tumor genomes |
| Q51584233 | A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers |
| Q33513807 | A statistical change point model approach for the detection of DNA copy number variations in array CGH data |
| Q24816450 | A stepwise framework for the normalization of array CGH data |
| Q37789527 | A survey of analysis software for array-comparative genomic hybridisation studies to detect copy number variation |
| Q36199602 | A systems biology approach to defining metastatic biomarkers and signaling pathways |
| Q34486122 | A test for comparing two groups of samples when analyzing multiple omics profiles |
| Q31112364 | ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors. |
| Q31122219 | ADaCGH: A parallelized web-based application and R package for the analysis of aCGH data |
| Q47392240 | ATAD2 in cancer: a pharmacologically challenging but tractable target |
| Q31061489 | AccuTyping: new algorithms for automated analysis of data from high-throughput genotyping with oligonucleotide microarrays. |
| Q36023727 | Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B |
| Q34168766 | Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia |
| Q36344108 | Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer |
| Q34737360 | Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women |
| Q28299812 | All dosage compensation is local: gene-by-gene regulation of sex-biased expression on the chicken Z chromosome |
| Q38823738 | All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells |
| Q34107750 | Allele-specific disparity in breast cancer |
| Q47442140 | Allelic genome structural variations in maize detected by array comparative genome hybridization |
| Q53428679 | Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis |
| Q39923830 | Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells. |
| Q24321447 | Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins |
| Q40505869 | Amplicons on human chromosome 11q are located in the early/late-switch regions of replication timing |
| Q28264693 | Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer |
| Q39597950 | Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer |
| Q37472659 | Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer |
| Q34461120 | Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas |
| Q42249021 | Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer |
| Q35855473 | Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma |
| Q48921561 | An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning |
| Q30894750 | An array of insights: application of DNA chip technology in the study of cell biology |
| Q38610956 | An improved method for detecting and delineating genomic regions with altered gene expression in cancer |
| Q31026297 | An integrated strategy for the optimization of microarray data interpretation. |
| Q33579640 | An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer |
| Q42281045 | Anaconda: AN automated pipeline for somatic COpy Number variation Detection and Annotation from tumor exome sequencing data |
| Q33291410 | Analysis of array CGH data for cancer studies using fused quantile regression |
| Q39308117 | Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors |
| Q34439696 | Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. |
| Q37181116 | Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields |
| Q36533581 | Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. |
| Q24654413 | Aneuploidy: cells losing their balance |
| Q37633763 | Animal models of breast cancer for the study of pathogenesis and therapeutic insights. |
| Q33513312 | Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down |
| Q35821854 | Applications of array technology: melanoma research and diagnosis |
| Q35649312 | Applications of microarrays to histopathology |
| Q73383230 | Are cancers dependent on oncogenes or on aneuploidy? |
| Q33373553 | Array CGH data modeling and smoothing in Stationary Wavelet Packet Transform domain |
| Q36615332 | Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York |
| Q40534293 | Array comparative genomic hybridisation analysis of gamma-irradiated human thyrocytes |
| Q36141621 | Array comparative genomic hybridization and its applications in cancer |
| Q35012854 | Array-CGH and breast cancer |
| Q40394988 | Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer |
| Q34169994 | Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma |
| Q33276412 | Artificially introduced aneuploid chromosomes assume a conserved position in colon cancer cells |
| Q40059601 | Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors |
| Q42176126 | Assessing Population Level Genetic Instability via Moving Average |
| Q33295223 | Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays |
| Q35694379 | Assessment of palindromes as platforms for DNA amplification in breast cancer |
| Q60497033 | Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies |
| Q33277286 | Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material |
| Q96302472 | Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism |
| Q33793438 | Autoregressive higher-order hidden Markov models: exploiting local chromosomal dependencies in the analysis of tumor expression profiles |
| Q33875040 | BACOM: in silico detection of genomic deletion types and correction of normal cell contamination in copy number data |
| Q41893779 | BOOTSTRAP INFERENCE FOR NETWORK CONSTRUCTION WITH AN APPLICATION TO A BREAST CANCER MICROARRAY STUDY. |
| Q37145619 | Bayesian Frequentist hybrid Model wth Application to the Analysis of Gene Copy Number Changes |
| Q34178052 | Bayesian Hidden Markov Modeling of Array CGH Data |
| Q30656573 | Bayesian Mixture Models for Assessment of Gene Differential Behaviour and Prediction of pCR through the Integration of Copy Number and Gene Expression Data |
| Q33879564 | Bayesian Random Segmentation Models to Identify Shared Copy Number Aberrations for Array CGH Data |
| Q37594079 | Bilateral ovarian carcinomas differ in the expression of metastasis-related genes |
| Q38463937 | Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma |
| Q35885829 | Bioinformatics and cancer target discovery |
| Q33219782 | Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling |
| Q36427239 | Bioinformatics for cancer management in the post-genome era. |
| Q36680058 | Biomarker discovery in epithelial ovarian cancer by genomic approaches. |
| Q37121911 | CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer |
| Q25257143 | CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays |
| Q64118595 | CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival |
| Q24318511 | CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer |
| Q40950455 | CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion. |
| Q58576718 | CDK5 Functions as a Tumor Promoter in Human Lung Cancer |
| Q36414685 | CDX2 is an amplified lineage-survival oncogene in colorectal cancer |
| Q21133928 | COPS: a sensitive and accurate tool for detecting somatic Copy Number Alterations using short-read sequence data from paired samples |
| Q36909580 | Cancer Karyotypes: Survival of the Fittest |
| Q34962407 | Cancer gene discovery in mouse and man. |
| Q34207183 | Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: a comparative review |
| Q35587062 | Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN |
| Q24794098 | Caryoscope: an Open Source Java application for viewing microarray data in a genomic context |
| Q35782909 | Cell cycle gene expression networks discovered using systems biology: Significance in carcinogenesis |
| Q36296457 | Challenges in Identifying Candidate Amplification Targets in Human Cancers: Chromosome 8q21 as a Case Study |
| Q37425361 | Challenges in cancer research and multifaceted approaches for cancer biomarker quest. |
| Q91620746 | Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness |
| Q36916665 | Characterization of breast cancer by array comparative genomic hybridization. |
| Q36706884 | Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease |
| Q35010185 | Characterizing the physical genome |
| Q90226583 | Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer |
| Q36509335 | Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome |
| Q31082158 | Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas |
| Q35201471 | Chromosome aberrations in solid tumors |
| Q57133907 | Chromosome instability leaves its mark |
| Q35829179 | Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations |
| Q35646744 | Chromosome mis-segregation and cytokinesis failure in trisomic human cells |
| Q36634493 | Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells |
| Q47138268 | Chromosome-scale mega-haplotypes enable digital karyotyping of cancer aneuploidy |
| Q35062466 | Classification of cancers by expression profiling |
| Q35623360 | Clinical implications of advanced molecular cytogenetics in cancer |
| Q38031599 | Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key? |
| Q33656571 | Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data |
| Q37233367 | Coactivator function defines the active estrogen receptor alpha cistrome |
| Q34457353 | Combined analysis of genome-wide expression and copy number profiles to identify key altered genomic regions in cancer. |
| Q81099908 | Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification |
| Q37148663 | Combining chromosomal arm status and significantly aberrant genomic locations reveals new cancer subtypes |
| Q36710395 | Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma |
| Q57274907 | Common and Contrasting Genomic Profiles among the Major Human Lung Cancer Subtypes |
| Q40622666 | Common malignancy-associated regions of transcriptional activation (MARTA) in human prostate, breast, ovarian, and colon cancers are targets for DNA amplification |
| Q30998407 | Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data |
| Q34156955 | Comparative analysis of algorithms for integration of copy number and expression data |
| Q28741909 | Comparative analysis of copy number variation detection methods and database construction |
| Q80353196 | Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model |
| Q24806069 | Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma |
| Q38519451 | Comparison of gene expression and DNA copy number changes in a murine model of lung cancer |
| Q39993558 | Comparison of whole genome amplification methods for further quantitative analysis with microarray-based comparative genomic hybridization |
| Q36882240 | Compensation of Dosage-Sensitive Genes on the Chicken Z Chromosome |
| Q53629713 | Comprehensive analysis of 19q12 amplicon in human gastric cancers. |
| Q34480698 | Comprehensive copy number profiles of breast cancer cell model genomes |
| Q37200314 | Computational Pathology: A Path Ahead |
| Q40907746 | Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo |
| Q33562300 | Conditional random pattern model for copy number aberration detection |
| Q81535537 | Conflicting evidence on the frequency of ESR1 amplification in breast cancer |
| Q38587997 | Consequences of Aneuploidy in Cancer: Transcriptome and Beyond |
| Q90242669 | Context is everything: aneuploidy in cancer |
| Q38440216 | Contribution of gross chromosomal changes to HPV16-induced transformation |
| Q39044545 | Corrections for mRNA extraction and sample normalization errors find increased mRNA levels may compensate for cancer haplo-insufficiency |
| Q45416031 | Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma |
| Q36694963 | Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses |
| Q81414358 | Coupled analysis of gene expression and chromosomal location |
| Q91625805 | Coupling of DNA Replication and Negative Feedback Controls Gene Expression for Cell-Fate Decisions |
| Q40238953 | Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors |
| Q35188471 | Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines. |
| Q37750063 | Current controversies in the management of breast cancer |
| Q30490635 | Cyfip1 is a putative invasion suppressor in epithelial cancers |
| Q24316471 | D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells |
| Q60921246 | DBS: a fast and informative segmentation algorithm for DNA copy number analysis |
| Q36453102 | DNA Methylation Profiling Distinguishes Three Clusters of Breast Cancer Cell Lines |
| Q39902217 | DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. |
| Q83919563 | DNA copy number amplification profiling of human neoplasms |
| Q37055967 | DNA copy number analysis in gastrointestinal stromal tumors using gene expression microarrays. |
| Q37258955 | DNA microarray and proteomic strategies for understanding alcohol action |
| Q35172272 | DNA microarrays: translation of the genome from laboratory to clinic |
| Q39922875 | DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC). |
| Q33520629 | DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data |
| Q28748990 | Data integration in genetics and genomics: methods and challenges |
| Q35790266 | Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines |
| Q35188897 | Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response |
| Q33808510 | Detecting cancer gene networks characterized by recurrent genomic alterations in a population |
| Q42059778 | Detecting genomic aberrations using products in a multiscale analysis |
| Q37346833 | Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH. |
| Q38068938 | Detection and interpretation of genomic structural variation in health and disease. |
| Q36943634 | Detection of DNA copy number alterations in cancer by array comparative genomic hybridization |
| Q37695006 | Detection of candidate tumor driver genes using a fully integrated Bayesian approach |
| Q37384126 | Detection of recurrent copy number alterations in the genome: taking among-subject heterogeneity seriously |
| Q36537299 | Development of a DNA-labeling system for array-based comparative genomic hybridization |
| Q34358592 | Different gene expression patterns in invasive lobular and ductal carcinomas of the breast |
| Q55096489 | Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes. |
| Q35848430 | Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction |
| Q52967770 | Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma |
| Q34152841 | Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis |
| Q42499457 | Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer |
| Q28384678 | Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development |
| Q34071394 | Drosophila duplication hotspots are associated with late-replicating regions of the genome |
| Q34923557 | Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma |
| Q42566761 | Dynamics of gene duplication and transposons in microbial genomes following a sudden environmental change |
| Q34268216 | EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer |
| Q35427604 | Early detection in head and neck cancer - current state and future perspectives |
| Q38629879 | Effects of aneuploidy on gene expression: implications for cancer |
| Q42108619 | Efficient high-resolution deletion discovery in Caenorhabditis elegans by array comparative genomic hybridization |
| Q35625533 | Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk |
| Q40006128 | Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells |
| Q33294653 | Elucidating the altered transcriptional programs in breast cancer using independent component analysis |
| Q48164333 | Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization. |
| Q38666500 | Estimating relative mitochondrial DNA copy number using high throughput sequencing data. |
| Q41906788 | Estimation of a non-parametric variable importance measure of a continuous exposure |
| Q34341395 | Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1 |
| Q40347331 | Evaluation of hierarchical models for integrative genomic analyses |
| Q35917147 | Evolution of dosage compensation under sexual selection differs between X and Z chromosomes |
| Q33942262 | Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome |
| Q33387269 | Experimental design and data analysis for array comparative genomic hybridization |
| Q31097345 | Exploiting noise in array CGH data to improve detection of DNA copy number change |
| Q33774231 | Expression and Transcriptional Regulation of Human ATP6V1A Gene in Gastric Cancers. |
| Q35794390 | Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine. |
| Q46933194 | Expression profiling of breast cancer, influence of tumor genotype and patient genotype. |
| Q33477584 | Extensions of sparse canonical correlation analysis with applications to genomic data |
| Q28602790 | Fast Bayesian Inference of Copy Number Variants using Hidden Markov Models with Wavelet Compression |
| Q30479616 | Flexible and accurate detection of genomic copy-number changes from aCGH. |
| Q38349207 | Focal amplification and oncogene dependency of GAB2 in breast cancer |
| Q33633583 | Fragile genomic sites are associated with origins of replication. |
| Q34329066 | Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression |
| Q33246807 | Frequent occurrence of uniparental disomy in colorectal cancer |
| Q79252391 | From array to array: confirmation of genomic gains and losses discovered by array-based comparative genomic hybridization utilizing fluorescence in situ hybridization on tissue microarrays |
| Q30274633 | Functional characterization of the MENTAL domain |
| Q36344203 | Functional genomics and transcriptomics of prostate cancer: promises and limitations |
| Q88600058 | Functional interaction-based nonlinear models with application to multiplatform genomics data |
| Q33509304 | Gene copy number analysis for family data using semiparametric copula model. |
| Q24676993 | Gene copy number variation spanning 60 million years of human and primate evolution |
| Q57837779 | Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization |
| Q42502797 | Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes |
| Q30724775 | Gene expression in cancer: the application of microarrays |
| Q35843266 | Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans |
| Q44394270 | Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas |
| Q33290349 | Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines. |
| Q35572479 | Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics |
| Q36200413 | Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer |
| Q36965154 | Gene set enrichment analysis using linear models and diagnostics |
| Q33412610 | Gene set-based module discovery in the breast cancer transcriptome |
| Q36509342 | Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/β-Catenin Pathway in Colorectal Cancer |
| Q35108760 | Genetic Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility |
| Q24798750 | Genetic alteration and gene expression modulation during cancer progression |
| Q34537800 | Genetic regulators of large-scale transcriptional signatures in cancer |
| Q33713239 | Genome profiling of ERBB2-amplified breast cancers |
| Q53485693 | Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients |
| Q45981330 | Genome-wide analysis of barcoded Saccharomyces cerevisiae gene-deletion mutants in pooled cultures. |
| Q28283932 | Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome |
| Q33296347 | Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization |
| Q33239655 | Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer |
| Q38436572 | Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast |
| Q37039555 | Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer |
| Q34188440 | Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene |
| Q36043493 | Genomic approaches in the management and treatment of breast cancer |
| Q37324821 | Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China |
| Q94474058 | Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma |
| Q41211788 | Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. |
| Q34964303 | Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer |
| Q33687781 | Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer |
| Q39880703 | Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development |
| Q33998514 | Genomic instability in breast cancer: pathogenesis and clinical implications |
| Q35198389 | Genomic microarrays in human genetic disease and cancer |
| Q33340988 | Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer |
| Q24610167 | Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer |
| Q37360179 | Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes |
| Q47115540 | Genomic regression analysis of coordinated expression |
| Q36465250 | Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer |
| Q35648379 | Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours? |
| Q38003668 | Germline copy number variations and cancer predisposition. |
| Q33414658 | Global associations between copy number and transcript mRNA microarray data: an empirical study. |
| Q35574282 | Global survey of chromatin accessibility using DNA microarrays. |
| Q28541555 | High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner |
| Q25257525 | High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization |
| Q35587691 | High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides |
| Q36610257 | High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer |
| Q36465618 | High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer |
| Q38332865 | High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry |
| Q40646024 | High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes |
| Q51593877 | High-resolution analysis of chromosomal imbalances using the Affymetrix 10K SNP genotyping chip |
| Q33440056 | High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors |
| Q34770064 | High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression |
| Q33196614 | High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization |
| Q38441193 | High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. |
| Q34834994 | High-resolution characterization of the pancreatic adenocarcinoma genome |
| Q33826097 | High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes |
| Q40490949 | High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer |
| Q24530598 | High-resolution genomic profiles of human lung cancer |
| Q34106761 | High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs |
| Q40631847 | High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays |
| Q34768680 | High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer |
| Q30436256 | Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers |
| Q48480777 | Homage to Theodor Boveri (1862-1915): Boveri's theory of cancer as a disease of the chromosomes, and the landscape of genomic imbalances in human carcinomas |
| Q45974107 | Hybrid algorithms for multiple change-point detection in biological sequences. |
| Q99400721 | Identification and prognostic value of metabolism-related genes in gastric cancer |
| Q40595739 | Identification and validation of an ERBB2 gene expression signature in breast cancers |
| Q45557173 | Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis |
| Q40037487 | Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling. |
| Q24796224 | Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH |
| Q31142505 | Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data |
| Q33553289 | Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis |
| Q33907993 | Identification of drivers from cancer genome diversity in hepatocellular carcinoma |
| Q58739892 | Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis |
| Q54504858 | Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics. |
| Q39901210 | Identification of genes that exhibit changes in expression on the 8p chromosomal arm by the Systematic Multiplex RT-PCR (SM RT-PCR) and DNA microarray hybridization methods. |
| Q38305699 | Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. |
| Q37214325 | Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers |
| Q37413653 | Identification of metastasis-associated genes in colorectal cancer through an integrated genomic and transcriptomic analysis |
| Q42478400 | Identification of molecular apocrine breast tumours by microarray analysis. |
| Q21245740 | Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling |
| Q37360110 | Identification of potential driver genes in human liver carcinoma by genomewide screening |
| Q28288078 | Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach |
| Q35256884 | Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma. |
| Q38518433 | Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses |
| Q34787147 | Identification of the NEDD4L Gene as a Prognostic Marker by Integrated Microarray Analysis of Copy Number and Gene Expression Profiling in Non-small Cell Lung Cancer |
| Q30587051 | Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data |
| Q33771056 | Identifying subtype-specific associations between gene expression and DNA methylation profiles in breast cancer |
| Q37303817 | Importance of rare gene copy number alterations for personalized tumor characterization and survival analysis |
| Q34542457 | Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma |
| Q37428060 | Individual karyotypes at the origins of cervical carcinomas |
| Q45794856 | IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals |
| Q35986538 | Inference of tumor phylogenies from genomic assays on heterogeneous samples |
| Q33977659 | Inferring causal genomic alterations in breast cancer using gene expression data |
| Q40903957 | Inferring combinatorial association logic networks in multimodal genome-wide screens. |
| Q41134618 | Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins |
| Q28080281 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention |
| Q28397049 | Integrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer Metastasis |
| Q34026325 | Integrated analyses of copy number variations and gene expression in lung adenocarcinoma |
| Q28730850 | Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma |
| Q30490621 | Integrated analysis of DNA copy number and gene expression microarray data using gene sets |
| Q48252205 | Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities |
| Q33881798 | Integrated analysis of gene expression and copy number data on gene shaving using independent component analysis |
| Q57270554 | Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q |
| Q33968921 | Integrated genomics of ovarian xenograft tumor progression and chemotherapy response |
| Q80402791 | Integrated global profiling of cancer |
| Q60910638 | Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma |
| Q41890841 | Integrated study of copy number states and genotype calls using high-density SNP arrays |
| Q37968654 | Integrating breast cancer genetics into clinical practice. |
| Q31038779 | Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel |
| Q26782613 | Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential |
| Q46190356 | Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer |
| Q36152246 | Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer |
| Q28271520 | Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target |
| Q33670486 | Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition |
| Q30495169 | Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival |
| Q38516793 | Integrative analysis of a cancer somatic mutome |
| Q33557657 | Integrative analysis of gene expression and copy number alterations using canonical correlation analysis |
| Q37010330 | Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes |
| Q28396741 | Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old |
| Q33503982 | Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis |
| Q34029818 | Integrative epigenomic and genomic analysis of malignant pheochromocytoma |
| Q36487126 | Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer |
| Q40007526 | Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma |
| Q31059566 | Integrative subtype discovery in glioblastoma using iCluster |
| Q35888918 | Inter-chromosomal variation in the pattern of human population genetic structure |
| Q39239067 | Isolation and Characterization of Cancer Stem Cells In Vitro |
| Q33557528 | JISTIC: identification of significant targets in cancer. |
| Q30885702 | Karyotypic evolutions of cancer species in rats during the long latent periods after injection of nitrosourea |
| Q39633864 | LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling |
| Q30489312 | Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers |
| Q37939073 | Lessons from a decade of integrating cancer copy number alterations with gene expression profiles |
| Q21092827 | Lineage-specific gene duplication and loss in human and great ape evolution |
| Q33910433 | Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer |
| Q33988589 | Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles |
| Q34267035 | Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes |
| Q35731663 | Loss of heterozygosity: what is it good for? |
| Q24800138 | M-CGH: analysing microarray-based CGH experiments |
| Q33694015 | MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome |
| Q24651422 | MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer |
| Q57690359 | MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene |
| Q33449289 | Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer |
| Q34417159 | Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? |
| Q34257684 | Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses. |
| Q60203690 | Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors |
| Q34591242 | Metabolomics: building on a century of biochemistry to guide human health |
| Q40640337 | Metastatic lymph node 64 (MLN64), a gene overexpressed in breast cancers, is regulated by Sp/KLF transcription factors |
| Q40575587 | Method for manufacturing whole-genome microarrays by rolling circle amplification |
| Q42801596 | Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications |
| Q48102903 | Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets. |
| Q39536347 | Microarray and its applications |
| Q21266591 | Microarray karyotyping of commercial wine yeast strains reveals shared, as well as unique, genomic signatures |
| Q36177378 | Microarrays in veterinary diagnostics |
| Q42919521 | Microwave-Mediated Synthesis of Labeled Nucleotides with Utility in the Synthesis of DNA Probes |
| Q30838107 | Mining TCGA data using Boolean implications |
| Q35108751 | Molecular Characterization of Breast Cancer Aggressiveness |
| Q36579305 | Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. |
| Q83513596 | Molecular biomarkers involved in the tumor dedifferentiation process of thyroid carcinoma of epithelial origin: perspectives |
| Q34807023 | Molecular classification of familial non-BRCA1/BRCA2 breast cancer |
| Q51939495 | Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays |
| Q37542255 | Molecular markers of breast axillary lymph node metastasis |
| Q38150909 | Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities |
| Q33479152 | Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery |
| Q35084886 | Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB |
| Q37598935 | Molecular profiling of laryngeal cancer |
| Q24634248 | Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers |
| Q41949567 | Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1. |
| Q33403662 | Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells |
| Q89792595 | Multi-omics Data Integration, Interpretation, and Its Application |
| Q92538631 | Multilayered Tuning of Dosage Compensation and Z-Chromosome Masculinization in the Wood White (Leptidea sinapis) Butterfly |
| Q30631788 | Multisample aCGH data analysis via total variation and spectral regularization. |
| Q31028324 | Multivariate Boosting for Integrative Analysis of High-Dimensional Cancer Genomic Data |
| Q34347579 | Mutation of GATA3 in human breast tumors |
| Q35920494 | Myc proteins in brain tumor development and maintenance |
| Q39551687 | Network modeling of the transcriptional effects of copy number aberrations in glioblastoma |
| Q37574324 | New insights into the troubles of aneuploidy |
| Q49478791 | Nonlinear Joint Latent Variable Models and Integrative Tumor Subtype Discovery |
| Q43480931 | Nonparametric testing for DNA copy number induced differential mRNA gene expression |
| Q35173695 | Novel patterns of genome rearrangement and their association with survival in breast cancer |
| Q47399899 | Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer |
| Q45196334 | Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization |
| Q37217158 | Nuclear receptor coregulators as a new paradigm for therapeutic targeting |
| Q24678477 | Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer |
| Q42513050 | Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells |
| Q35886756 | Overexpressed oncogenic tumor-self antigens |
| Q37447976 | Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction |
| Q28285857 | Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma |
| Q36571451 | Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer. |
| Q36206503 | PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer |
| Q45271498 | PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas |
| Q30471421 | Parsimonious Higher-Order Hidden Markov Models for Improved Array-CGH Analysis with Applications to Arabidopsis thaliana |
| Q26786127 | Patterns of Chromosomal Aberrations in Solid Tumors |
| Q35864949 | Penalized weighted low-rank approximation for robust recovery of recurrent copy number variations |
| Q46796492 | Piecewise-constant and low-rank approximation for identification of recurrent copy number variations. |
| Q30476046 | Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions |
| Q38514215 | Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions |
| Q37327531 | Precise inference of copy number alterations in tumor samples from SNP arrays |
| Q38438763 | Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma. |
| Q31067056 | Prediction of chromosomal aneuploidy from gene expression data. |
| Q28742950 | Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting |
| Q35945546 | Preservation of skin DNA for oligonucleotide array CGH studies: a feasibility study |
| Q29616779 | Principles of cancer therapy: oncogene and non-oncogene addiction |
| Q35089389 | Profiling cancer |
| Q35780955 | Programmed Genome Rearrangements in the Ciliate Oxytricha |
| Q33686899 | Proteomic changes resulting from gene copy number variations in cancer cells |
| Q28252569 | RCP is a human breast cancer-promoting gene with Ras-activating function |
| Q41857308 | RETRACTED: Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network |
| Q40278421 | RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes |
| Q34284546 | RNA-Seq and human complex diseases: recent accomplishments and future perspectives. |
| Q34438332 | RNA-mediated epigenetic regulation of DNA copy number |
| Q33951424 | Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data |
| Q35956872 | Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders |
| Q36313208 | Recent advances in array comparative genomic hybridization technologies and their applications in human genetics |
| Q52653017 | Recurrent copy number alterations in young women with breast cancer. |
| Q36341467 | Recurrent transcriptional clusters in the genome of mouse pluripotent stem cells |
| Q33911611 | Reduced rank regression via adaptive nuclear norm penalization |
| Q37270376 | Reducing the complexity of complex gene coexpression networks by coupling multiweighted labeling with topological analysis |
| Q40209266 | Regional copy number-independent deregulation of transcription in cancer |
| Q43512760 | Regression models, scan statistics and reappearance probabilities to detect regions of association between gene expression and copy number |
| Q37528144 | Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer |
| Q64969914 | Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders. |
| Q37419573 | Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer |
| Q37375397 | Road to the crossroads of life and death: linking sister chromatid cohesion and separation to aneuploidy, apoptosis and cancer |
| Q36419981 | SAGE and related approaches for cancer target identification |
| Q34009701 | SMURF1 amplification promotes invasiveness in pancreatic cancer |
| Q28710136 | SNP microarray analyses reveal copy number alterations and progressive genome reorganization during tumor development in SVT/t driven mice breast cancer |
| Q37714736 | SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women |
| Q30768936 | SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS. |
| Q40275982 | Scanning copy number and gene expression on the 16p13.3-13.2 chromosomal region by the systematic multiplex polymerase chain reaction and reverse transcription-polymerase chain reaction methods |
| Q33367138 | Segmental duplications arise from Pol32-dependent repair of broken forks through two alternative replication-based mechanisms |
| Q33736439 | Segmentation of genomic and transcriptomic microarrays data reveals major correlation between DNA copy number aberrations and gene-loci expression |
| Q53209834 | Segmented regression, a versatile tool to analyze mRNA levels in relation to DNA copy number aberrations |
| Q28741460 | Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer |
| Q42566509 | Sensitive and accurate detection of copy number variants using read depth of coverage |
| Q41600805 | Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer |
| Q39932632 | Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis |
| Q34395225 | Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice |
| Q34459632 | Simple binary segmentation frameworks for identifying variation in DNA copy number |
| Q42228486 | Simple derivation of transgene-free iPS cells by a dual recombinase approach |
| Q44771916 | Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma |
| Q92447495 | Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells |
| Q36954927 | Small-scale copy number variation and large-scale changes in gene expression. |
| Q34173332 | Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion |
| Q24648102 | Somatic mutations affect key pathways in lung adenocarcinoma |
| Q33367131 | Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response |
| Q35749438 | Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas |
| Q39175219 | Sparse multivariate factor analysis regression models and its applications to integrative genomics analysis |
| Q31041638 | Spatial normalization of array-CGH data |
| Q36629194 | Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature |
| Q33776517 | Statistical analysis of the cancer cell's molecular entropy using high-throughput data |
| Q34339885 | Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer |
| Q33541370 | Statistics and bioinformatics in nutritional sciences: analysis of complex data in the era of systems biology |
| Q33688989 | Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer |
| Q57032028 | Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes |
| Q59789265 | Systematic identification of mutations and copy number alterations associated with cancer patient prognosis |
| Q39019239 | THE SCREENING AND RANKING ALGORITHM FOR CHANGE-POINTS DETECTION IN MULTIPLE SAMPLES. |
| Q35078761 | TP53 and breast cancer |
| Q39153926 | TPD52 represents a survival factor in ERBB2-amplified breast cancer cells. |
| Q56966016 | TRAF4 overexpression is a common characteristic of human carcinomas |
| Q37132817 | TRAF4, at the Crossroad between Morphogenesis and Cancer |
| Q33847811 | Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction |
| Q37204063 | Targeting EZH2 for cancer therapy: progress and perspective. |
| Q38306484 | Targets of genome copy number reduction in primary breast cancers identified by integrative genomics |
| Q36303996 | Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer |
| Q53542222 | The BAC resource: tools for array CGH and FISH. |
| Q34071198 | The W, X, Y and Z of sex-chromosome dosage compensation. |
| Q26995532 | The consequences of chromosomal aneuploidy on the transcriptome of cancer cells |
| Q24803014 | The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions |
| Q89144664 | The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions |
| Q36043417 | The evolution of gene expression and the transcriptome-phenotype relationship. |
| Q33745941 | The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis |
| Q34416425 | The human cancer genome project--one more misstep in the war on cancer |
| Q40258450 | The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study |
| Q36445020 | The progress on genetic analysis of nasopharyngeal carcinoma |
| Q42481244 | The role of S100 genes in breast cancer progression |
| Q37687220 | The role of histone modifications and variants in regulating gene expression in breast cancer. |
| Q36344271 | The role of microarray technologies in the study of soft tissue tumours |
| Q51840461 | The sigmoidal curve of cancer |
| Q34248355 | The stable traits of melanoma genetics: an alternate approach to target discovery |
| Q21128645 | The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum |
| Q55660623 | Tissue Specificity and Dynamics of Sex-Biased Gene Expression in a Common Frog Population with Differentiated, Yet Homomorphic, Sex Chromosomes. |
| Q36573836 | Tissue detection of biomolecular predictors in breast cancer |
| Q33289823 | Toward accurate high-throughput SNP genotyping in the presence of inherited copy number variation |
| Q36439819 | Trade-off between selection for dosage compensation and masculinization on the avian Z chromosome |
| Q43137043 | Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer. |
| Q51022990 | Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells. |
| Q40540347 | Unstable genomes elevate transcriptome dynamics |
| Q30808425 | Using XHMM Software to Detect Copy Number Variation in Whole-Exome Sequencing Data |
| Q48698068 | Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. |
| Q30656126 | Using large-scale molecular data sets to improve breast cancer treatment |
| Q35873673 | Using microarrays to predict resistance to chemotherapy in cancer patients |
| Q33870491 | Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma |
| Q24815370 | Visualization-based discovery and analysis of genomic aberrations in microarray data |
| Q35683652 | When One and One Gives More than Two: Challenges and Opportunities of Integrative Omics |
| Q34373539 | Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. |
| Q42171696 | Widespread duplications in the genomes of laboratory stocks of Dictyostelium discoideum |
| Q54518412 | [Different coexisting genotypes in the breast cancer cell line MDA-MB-468]. |
| Q36543286 | bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses |
| Q53340770 | c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells |
| Q24796016 | cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma |
| Q36249808 | iGC-an integrated analysis package of gene expression and copy number alteration. |
| Q36393797 | integIRTy: a method to identify genes altered in cancer by accounting for multiple mechanisms of regulation using item response theory |
| Q36902949 | miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs |
| Q50909522 | tmle.npvi: targeted, integrative search of associations between DNA copy number and gene expression, accounting for DNA methylation |
Search more.